Immunize Rx, LLC is categorized under Travelers' Health Counseling/Vaccinations in Kent, WA and active since 2009.
Immunize Rx, LLC was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Travelers' Health Counseling/Vaccinations business, which does work in the B2C market, and is classified as a Travelers' Health Counseling/Vaccinations, under code number by the NAICS.
If you are seeking more information, feel free to contact Paul Thompson at the company’s single location by writing to 25329 74th Avenue S # 101, Kent, Washington WA 98032 or by phoning (253) 239-3004. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Immunize Rx, LLC |
| Contact Person: | Paul Thompson |
| Address: | 25329 74th Avenue S # 101, Kent, Washington 98032 |
| Phone Number: | (253) 239-3004 |
| Website Address: | immunizerx.com |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Travelers' Health Counseling/Vaccinations |
| Share This Business: |
Immunize Rx, LLC was started in 2009 to provide professional Travelers' Health Counseling/Vaccinations under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Paul Thompson for inquiries that concern Immunize Rx, LLC by calling the company number (253) 239-3004, as your correspondence is most welcome. Additionally, the physical location of the single location of Immunize Rx, LLC can be found at the coordinates 47.37616,-122.23825 as well as the street address 25329 74th Avenue S # 101 in Kent, Washington 98032.
For its online presence, you may visit Immunize Rx, LLC’s website at immunizerx.com and engage with its social media outlets through on Twitter and on Facebook.